ECZEMA
Clinical trials for ECZEMA explained in plain language.
Never miss a new study
Get alerted when new ECZEMA trials appear
Sign up with your email to follow new studies for ECZEMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for kids with severe eczema: drug trial shows promise
Disease control OngoingThis study tests a medicine called lebrikizumab in children aged 6 months to under 18 years with moderate-to-severe eczema (atopic dermatitis). The goal is to see if it improves skin condition and reduces itching compared to a placebo. About 367 participants will receive either t…
Matched conditions: ECZEMA
Phase: PHASE3 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated May 14, 2026 12:05 UTC
-
New hope for kids with severe eczema: Long-Term drug study launches
Disease control ENROLLING_BY_INVITATIONThis study looks at the long-term safety and effectiveness of lebrikizumab for children aged 6 months to under 18 years with moderate-to-severe atopic dermatitis (eczema). About 310 participants who completed a previous lebrikizumab study will receive the drug for up to 68 weeks,…
Matched conditions: ECZEMA
Phase: PHASE3 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated May 12, 2026 13:44 UTC
-
Eczema treatment breakthrough? new dosing could mean fewer shots
Disease control OngoingThis study tests the drug lebrikizumab in 520 adults and teens (ages 12+) with moderate-to-severe eczema. The goal is to see if a new, less frequent dosing schedule (every 12 weeks) works as well as the current one (every 4 weeks) at controlling skin symptoms. Participants will r…
Matched conditions: ECZEMA
Phase: PHASE3 • Sponsor: Almirall, S.A. • Aim: Disease control
Last updated May 11, 2026 20:40 UTC
-
Baby lotion breakthrough? study aims to stop food allergies before they start
Prevention OngoingThis study tests whether a special skin care routine can prevent food allergies in infants who develop eczema by 12 weeks old. About 400 babies will use a barrier cream and an anti-inflammatory cream twice daily, compared to standard care. The goal is to see if this proactive app…
Matched conditions: ECZEMA
Phase: PHASE2 • Sponsor: Kari Nadeau, MD, PhD • Aim: Prevention
Last updated May 17, 2026 02:05 UTC
-
New eczema drug shows promise in Mid-Stage trial
Symptom relief OngoingThis study tests a new drug called ATI-045 in 110 adults with moderate-to-severe atopic dermatitis (eczema). Half receive the drug, half receive a placebo, and neither the patients nor doctors know who gets which. The main goal is to see if ATI-045 reduces eczema severity and itc…
Matched conditions: ECZEMA
Phase: PHASE2 • Sponsor: Aclaris Therapeutics, Inc. • Aim: Symptom relief
Last updated May 04, 2026 16:31 UTC
-
Eczema gene hunt: 300 latinx patients join landmark study
Knowledge-focused ENROLLING_BY_INVITATIONThis study looks for specific gene changes (filaggrin mutations) in 300 Latinx adults with eczema. Researchers want to understand how these gene changes relate to the disease in this group. The goal is to learn more, not to test a new treatment.
Matched conditions: ECZEMA
Sponsor: University of Pennsylvania • Aim: Knowledge-focused
Last updated May 14, 2026 12:06 UTC
-
Scientists hunt for clues to Kids' eczema in skin and blood
Knowledge-focused OngoingThis study looks at skin and blood samples from 505 children with eczema (atopic dermatitis) to find biological markers that explain the disease. Researchers compare these markers to those in adults to better understand what causes eczema in kids. No new treatments are tested; th…
Matched conditions: ECZEMA
Sponsor: Northwestern University • Aim: Knowledge-focused
Last updated May 13, 2026 16:02 UTC